# Six-figure data offers: what the headline does and does not tell you

https://licensethedata.com/blog/advertised-payouts-vs-seller-outcomes/

An evidence ladder for separating advertised compensation, indicative estimates, written offers and money actually received.

Published 2026-10-13. 4 minute read.

## A large advertised number answers a narrow question

micro1’s data-partnership page advertises $100k+, $500k+ and $1M+ tiers for differently described contributions. Handshake advertises partnerships from $100K to $4M+ depending on the data. These statements show that providers are positioning operational data as a potentially substantial transaction. They do not establish what a typical applicant receives.

The analytical mistake is to turn a provider’s advertised tier into a seller outcome. An owner still needs to know which businesses qualify, what rights the amount purchases, what conditions apply and whether the number represents one payment or a longer arrangement. micro1’s inspected page does not specify a period for its tier amounts.



Source: micro1: Enterprise Data Partnerships — https://www.micro1.ai/data-partnerships
Source: Handshake AI: Data Partnerships — https://joinhandshake.com/ai/data-partnerships

## Use four evidence levels instead of one “payout” label

We propose an evidence ladder that makes the commercial stage explicit. An advertisement says what a provider promotes. An indicative estimate applies a model or calculator to limited inputs. A written offer proposes an amount for a particular scope and set of conditions. A received payment documents money arriving under a transaction.

Handshake itself says its calculator is indicative and not an offer. That distinction should remain visible when someone shares a screenshot. An estimate can be useful for a scoping conversation without being evidence of what a buyer is obligated to pay.

- Advertisement: attribute the number to the provider and preserve its stated scope.
- Indicative estimate: show the assumptions and the not-an-offer qualification.
- Written offer: record dataset scope, rights, deductions and acceptance conditions.
- Received payment: verify the payment stage without assuming it represents a typical seller.

Source: Handshake AI: Data Partnerships — https://joinhandshake.com/ai/data-partnerships

## A genuine partnership can still be an unsuitable comparable

Protege publishes a Gradient Health case describing seven-figure net-new revenue in under a year. Gradient’s own announcement confirms the partnership and supply of millions of de-identified medical-imaging studies, but does not disclose the revenue amount. The relationship has seller-side corroboration; the published revenue figure remains provider-hosted reporting.

That distinction matters twice. First, corroborating the partnership is not the same as independently auditing the payment. Second, a specialized imaging supplier is not a price comparable for a small company’s support-ticket archive. A real case can demonstrate possibility without supporting a general SMB valuation.



Source: Protege: Gradient Health Partnership Case — https://withprotege.ai/articles/blog/gradient-health-and-protege-partner-to-bring-multi-modal-scale-and-data-diversity-to-healthcare-ai
Source: Gradient Health: Protege Partnership Announcement — https://gradienthealth.io/blog/gradient-health-partners-protege

## Repeat-sales language is not a scheduled cash stream

Troveo says licensors earn on every sale and displays an illustrative example with an actual-terms disclaimer. Its timeline makes buyer demand part of the pace of first payment. The business model can involve additional sales, but the existence, timing and amount of those sales must not be assumed.

For any repeat-sale offer, request the definition of revenue, your share, permitted expenses, reporting frequency, payment due dates and audit provisions. A current Troveo share percentage was not verified in our research. Do not fill that gap with an indexed clause from a license-agreement URL that returned a 404.



Source: Troveo: Business Data — https://www.troveo.ai/business-data
Source: Troveo: How Long Does It Take to License Company Data? — https://www.troveo.ai/resources/how-long-to-license-company-data

## The missing denominator changes what you can conclude

In the research supporting this draft, we did not locate independently evidenced named small-business operating-data payouts for the core programs reviewed. That is a limitation of the research, not a claim that no company has been paid. We also lack an accepted-applicant denominator or a representative achieved-payout distribution.

Without that denominator, a successful transaction cannot establish a success rate. Without comparable rights and scope, an amount cannot establish your records’ value. Avoid “average earnings,” expected-income calculators and rankings based on the largest advertised figure.





## What an owner can do with imperfect evidence

Use public amounts as a reason to ask better questions, not as a forecast. Ask whether there is current demand for your particular records and request a written offer with explicit acceptance and rights terms. Compare retained proceeds and obligations only after the scopes are aligned.

This is a LicenseTheData.com educational analysis published on October 13, 2026, not a report of a transaction completed on that date. We have not received a licensing offer for the reader’s business, verified a payment for it or performed legal review.

- Keep marketing, estimates, offers and receipts in separate fields.
- Do not substitute provider hiring reviews for business-data seller evidence.
- Treat missing contractual details as questions, not favorable assumptions.


